INS and metabolic syndrome: Early-adiponectin-knockout mouse studies revealed a phenotype of impaired insulin sensitivity after exposure to an HFD [43,44], and importantly, it was found that the injection of adiponectin into mice improved insulin sensitivity and dyslipidemia [45].